Drug General Information
Drug ID
D00CAU
Former ID
DNC012109
Drug Name
N-(3,3-Dimethyl-cyclopentyl)-4-hexyloxy-benzamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526184]
Formula
C20H31NO2
Canonical SMILES
CCCCCCOC1=CC=C(C=C1)C(=O)NC2CCC(C2)(C)C
InChI
1S/C20H31NO2/c1-4-5-6-7-14-23-18-10-8-16(9-11-18)19(22)21-17-12-13-20(2,3)15-17/h8-11,17H,4-7,12-15H2,1-3H3,(H,21,22)
InChIKey
SPDGMSMRHOXECU-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Potassium voltage-gated channel subfamily KQT member 1 Target Info Inhibitor [526184]
KEGG Pathway Adrenergic signaling in cardiomyocytes
Cholinergic synapse
Gastric acid secretion
Pancreatic secretion
Protein digestion and absorption
Vibrio cholerae infection
PathWhiz Pathway Muscle/Heart Contraction
Reactome Voltage gated Potassium channels
WikiPathways SIDS Susceptibility Pathways
Potassium Channels
miR-targeted genes in muscle cell - TarBase
miR-targeted genes in lymphocytes - TarBase
TarBasePathway
References
Ref 526184J Med Chem. 2001 Nov 8;44(23):3764-7.Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockers.
Ref 526184J Med Chem. 2001 Nov 8;44(23):3764-7.Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockers.